Snehal Joshi on Muck Rack

Snehal Joshi

As seen in: Nature, Journal of Pharmacology and Experimental Therapeutics, International Journal of Radiation Oncology*Biology*Physics, Lung Cancer

Get in touch with Snehal

Contact Snehal, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Snehal Joshi’s Biography

Read Full Bio →

Vice President at HabileData.com is pioneer BPO Services and data Entry Company in India. Conducts business worldwide, our business is driven by committed, trained people integrated with innovative to deliver results i.e., reduced cost, time saved, increased productivity of its clients across United States, Canada, UK, Australia, France, Germany, Italy, UAE and other European nations.

Articles

Radiation in Combination with Immune Checkpoint Blockade and DNA Damage Response Inhibitors in Mice: Dosage Optimisation in MC38 Syngeneic Tumours via Modelling and Simulation

|
By David J. Hodson, Snehal Joshi, James Yates, Paul Farrington
| Journal of Pharmacology and Experimental Therapeutics
Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article. NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses. Your Email * Your Name * Send To * Enter multiple addresses on separate lines or separate them with commas.
Open in Who Shared View Duplicates (699) Issue with article?

Technical development and validation of a clinically applicable microenvironment classifier as a biomarker of tumour hypoxia for soft tissue sarcoma - British Journal of Cancer

|
By Laura Forker, Snehal Joshi
| Nature Verified
Abstract Background Soft tissue sarcomas (STS) are rare, heterogeneous tumours and biomarkers are needed to inform management. We previously derived a prognostic tumour microenvironment classifier (24-gene hypoxia signature). Here, we developed/validated an assay for clinical application. Methods Technical performance of targeted assays (Taqman low-density array, nanoString) was compared in 28 prospectively collected formalin-fixed, paraffin-embedded (FFPE) biopsies.
Open in Who Shared Issue with article?

Pretreatment Lymphocyte Count Predicts Benefit From Concurrent Chemotherapy With Radiotherapy in Oropharyngeal Cancer

|
By James Price, Snehal Joshi, Guy Betts, Eleanor J. Cheadle
| ascopubs.org
The worldwide annual incidence of oropharyngeal squamous cell carcinoma (OPSCC) is rising,1 largely because of an increased prevalence of high-risk human papillomavirus (HPV) infection.
Open in Who Shared Issue with article?
See all 11 articles
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified